New Cancer Treatment For Pancreatic, Stomach And Colon Cancer
Researchers found a way to develop new cancer treatments. The so called "collateral lethality" might be the answer to several types of cancer such as pancreatic, colon and stomach cancer. Collateral lethality is a therapeutic strategy uses passenger deleted genes as points of selective vulnerability.
Pancreatic, stomach and colon cancer are among the most common types of cancer. Colon cancer specifically is the third most common type of cancer which accounts to about 10 percent of cancer patients worldwide. Meanwhile, stomach cancer is the third most deadly type of cancer which makes up 7 percent of cancer cases and 9 percent of cancer deaths.
Typically, cancer cells deletes genes that suppress tumor formation. However, these deletions may also extend to neighboring genes with no direct role in the tumor progression in a process called collateral lethality. In a study published in Nature, on Wednesday, Jan. 18, scientists at The University of Texas MD Anderson Cancer discovered that this process can be used in novel therapy approaches for cancer.
"In an effort to expand therapeutic strategies beyond oncogenic targets to those not directly linked to cancer development, we have identified collateral lethal vulnerability in pancreatic cancers that can be targeted pharmacologically in certain patient populations," Prasenjit Dey, Ph.D., co-author of the study said, cited Science Daily. He added that genome data of several types of cancers reveal that this process might aid a new cancer treatment regime.
Doing a trial on mice, the researchers found out that when a common tumor suppressor in pancreatic cancer called SMAD4 is deleted during early cancer development, a nearby gene called malic enzyme 2 (ME2) is also eradicated. When the ME3 (sister gene to ME2) levels are depleted, it will lead to the regulation of branched chain amino acid (BCAA), which is important in cancer's ability to survive. This might be the key in preventing the growth of cancer tumors. The researchers added that more research is needed for the said cancer treatment.
Cancer Treatment: Best Therapy Found On Cancer's Genetic Script
Researchers create a tool which gives doctors the best personalized cancer treatment options for patients based on their genetic features.
Yellow Fever Outbreak In Brazil Kills 30, Officials Fear Epidemic
A yellow fever outbreak in Minas Gerais State in southeastern Brazil infected about 110 people and killed 30. Officials fear it might turn to an epidemic.
Schizophrenia Directly Linked To Diabetes
Diabetes risk increases upon onset of schizophrenia. Even removing other factors like diet, exercise and effects of antipsychotic drugs.
Fasting Diet Miracle: 5-Day Calorie Restriction Lowers Risk For Major Diseases
Researchers are calling a healthy fasting diet a miracle due to its amazing capability of lowering major chronic diseases including cancer and diabetes. A specifically designed diet that mimics fasting could be the answer to all our health problems.
General Vaccine For Cancer Not Likely
The search for a general cure for cancer is still being done. A general vaccine for cancer is not yet likely.
MORE IN ITECHPOST
At-Risk Mental Health for Students: Developing Resilience Among Students amid the Coronavirus Pandemic
At-Risk Mental Health for Students to help students struggling with their mental health, especially now amid the pandemic. It focuses more on developing students' resilience.
Tech Leaders and Health Authorities Join Forces, Launch New Initiative to Help Fight Pandemic and Future Epidemics
Two contact tracing apps have been successfully launched recently in Canada and Ireland. The open-source code underlying these apps has been contributed to a newly launched initiative to help other countries and U.S. states in the fight against the pandemic.
Fairy Tail Game Releases a Season Pass, a Week After It Was Launched
The anime RPG Fairy Tail from Koei Tecmo has just released a season pass that will release additional characters and content into the game, just a week after it was launched.